BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 7792436)

  • 21. Regulation of human airway surface liquid.
    Widdicombe JH; Widdicombe JG
    Respir Physiol; 1995 Jan; 99(1):3-12. PubMed ID: 7740210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.
    Lethem MI; James SL; Marriott C
    Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological approaches to discovery and development of new mucolytic agents.
    King M; Rubin BK
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1475-90. PubMed ID: 12458156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human DNase (rhDNase) influences phospholipid composition, surface activity, rheology and consecutively clearance indices of cystic fibrosis sputum.
    Griese M; App EM; Duroux A; Burkert A; Schams A
    Pulm Pharmacol Ther; 1997; 10(1):21-7. PubMed ID: 9344829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucins, mucus, and sputum.
    Voynow JA; Rubin BK
    Chest; 2009 Feb; 135(2):505-512. PubMed ID: 19201713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an airway mucus defect in the cystic fibrosis rat.
    Birket SE; Davis JM; Fernandez CM; Tuggle KL; Oden AM; Chu KK; Tearney GJ; Fanucchi MV; Sorscher EJ; Rowe SM
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacology of mucociliary transport].
    Lurie A; Pascal O; Castillon du Perron M; Grandordy B; Huchon G; Chrétien J
    Rev Mal Respir; 1985; 2(3):117-26. PubMed ID: 4081277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distearoyl phosphatidylglycerol liposomes improve surface and transport properties of CF mucus.
    Girod de Bentzmann S; Pierrot D; Fuchey C; Zahm JM; Morançais JL; Puchelle E
    Eur Respir J; 1993 Sep; 6(8):1156-61. PubMed ID: 8224130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanosensitive ATP release maintains proper mucus hydration of airways.
    Button B; Okada SF; Frederick CB; Thelin WR; Boucher RC
    Sci Signal; 2013 Jun; 6(279):ra46. PubMed ID: 23757023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions.
    Zahm JM; Debordeaux C; Maurer C; Hubert D; Dusser D; Bonnet N; Lazarus RA; Puchelle E
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1153-7. PubMed ID: 11316652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.
    Henderson AG; Ehre C; Button B; Abdullah LH; Cai LH; Leigh MW; DeMaria GC; Matsui H; Donaldson SH; Davis CW; Sheehan JK; Boucher RC; Kesimer M
    J Clin Invest; 2014 Jul; 124(7):3047-60. PubMed ID: 24892808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of methylxanthines on airway mucociliary function.
    Wanner A
    Am J Med; 1985 Dec; 79(6A):16-21. PubMed ID: 3002175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients.
    Deneuville E; Perrot-Minot C; Pennaforte F; Roussey M; Zahm JM; Clavel C; Puchelle E; de Bentzmann S
    Am J Respir Crit Care Med; 1997 Jul; 156(1):166-72. PubMed ID: 9230742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Airway Epithelial Differentiation and Mucociliary Clearance.
    Whitsett JA
    Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S143-S148. PubMed ID: 30431340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the depth and composition of airway surface liquid.
    Widdicombe JH
    J Anat; 2002 Oct; 201(4):313-8. PubMed ID: 12430955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucus Hyperconcentration as a Unifying Aspect of the Chronic Bronchitic Phenotype.
    Button B; Anderson WH; Boucher RC
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2(Suppl 2):S156-62. PubMed ID: 27115951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathologic bronchial secretions and mucociliary transport].
    Puchelle E
    Ann Anesthesiol Fr; 1980; 21(6):661-6. PubMed ID: 6111274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physiology and pathophysiology of bronchial secretion].
    Ficker JH
    Pneumologie; 2008 Mar; 62 Suppl 1():S11-3. PubMed ID: 18317975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.
    Tomkiewicz RP; App EM; Zayas JG; Ramirez O; Church N; Boucher RC; Knowles MR; King M
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1002-7. PubMed ID: 8214916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.